TearClear's Series B Round

TearClear raised a round of funding on February 14, 2019. Investors include Bluestem Capital Partners.

TearClear is an early-stage medical science company that is launching a proprietary chemical filter designed to safely deliver ophthalmic topical solutions. The company aims to assure long-term eye he…

Articles about TearClear's Series B Round: